These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 8173086)

  • 1. [Detecting impaired glucose tolerance based on medical decision making].
    Takahashi E; Yoshida K; Kondo T
    Nihon Koshu Eisei Zasshi; 1994 Mar; 41(3):237-42. PubMed ID: 8173086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.
    Mula-Abed WA; Al-Naemi AH
    Saudi Med J; 2003 May; 24(5):477-84. PubMed ID: 12847621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
    Adam JM; Tarigan NP
    Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Impact of lowering the cut-point for impaired fasting glucose on the distribution of impaired glucose regulation subcategories in Chinese adult population].
    Yang ZJ; Yang WY; Xiao JZ; Li GW; Wang Y
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1773-6. PubMed ID: 15631770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical screening examination for impaired glucose tolerance: is it possible to diagnose impaired glucose tolerance without a 75g oral glucose tolerance test?].
    Igarashi M
    Rinsho Byori; 2012 Apr; 60(4):349-55. PubMed ID: 22686045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke.
    Kernan WN; Viscoli CM; Inzucchi SE; Brass LM; Bravata DM; Shulman GI; McVeety JC
    Arch Intern Med; 2005 Jan; 165(2):227-33. PubMed ID: 15668371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new non-invasive technology to screen for dysglycaemia including diabetes.
    Ramachandran A; Moses A; Shetty S; Thirupurasundari CJ; Seeli AC; Snehalatha C; Singvi S; Deslypere JP
    Diabetes Res Clin Pract; 2010 Jun; 88(3):302-6. PubMed ID: 20188429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of sleep time with diabetes mellitus and impaired glucose tolerance.
    Gottlieb DJ; Punjabi NM; Newman AB; Resnick HE; Redline S; Baldwin CM; Nieto FJ
    Arch Intern Med; 2005 Apr; 165(8):863-7. PubMed ID: 15851636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using common clinical data improves the prediction of abnormal glucose tolerance by the new criteria of impaired fasting glucose: Tehran lipid and glucose study.
    Hadaegh F; Harati H; Ghasemi A; Tohidi M; Zabetian A; Mehrabi Y; Azizi F
    Diabetes Res Clin Pract; 2007 Sep; 77(3):459-64. PubMed ID: 17350133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine-tuning of prediction of isolated impaired glucose tolerance: a quantitative clinical prediction model.
    Rambod M; Hosseinpanah F; Ardakani EM; Padyab M; Azizi F
    Diabetes Res Clin Pract; 2009 Jan; 83(1):61-8. PubMed ID: 19012984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should oral glucose tolerance testing be mandatory following acute myocardial infarction?
    Jessani S; Gangopadhyay K; Patel JV; Lip GY; Millane T
    Int J Clin Pract; 2007 Apr; 61(4):680-3. PubMed ID: 17394440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting cut-offs in determining the prevalence of diabetes and intermediate glucose abnormality in a non-obese population.
    Sayeed MA; Mahtab H; Khanam PA; Keramat Ali SM; Chowdhury RI; Vaaler S; Hussain A; Azad Khan AK
    Bangladesh Med Res Counc Bull; 2004 Dec; 30(3):105-14. PubMed ID: 16240981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasting plasma glucose is not sufficient to detect ongoing glucose intolerance after pregnancy complicated by gestational diabetes.
    Kakad R; Anwar A; Dyer P; Webber J; Dale J
    Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):234-6. PubMed ID: 20162508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative evaluation of waist circumference, waist-to-hip ratio, waist-to-height ratio and body mass index as indicators of impaired glucose tolerance and as risk factors for type-2 diabetes mellitus.
    Łopatyński J; Mardarowicz G; Szcześniak G
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):413-9. PubMed ID: 15315025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance.
    Moreau F; Weiller MA; Rosner V; Weiss L; Hasselmann M; Pinget M; Kessler R; Kessler L
    Horm Metab Res; 2008 Jul; 40(7):502-6. PubMed ID: 18415892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated fasting triglycerides predict impaired glucose tolerance in adolescents at risk for type 2 diabetes.
    Love-Osborne K; Butler N; Gao D; Zeitler P
    Pediatr Diabetes; 2006 Aug; 7(4):205-10. PubMed ID: 16911007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal fructosamine and glycosylated haemoglobin in the prediction of gestational glucose intolerance.
    Aziz NL; Abdelwahab S; Moussa M; Georgy M
    Clin Exp Obstet Gynecol; 1992; 19(4):235-41. PubMed ID: 1294344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should we consider performing oral glucose tolerance tests more frequently in postmenopausal women for optimal screening of impaired glucose tolerance?
    Erenus M; Gurler AD; Elter K
    Menopause; 2002; 9(4):296-301. PubMed ID: 12082367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A hospital-based cross-sectional study to develop an estimation formula for 2-h post-challenge plasma glucose for screening impaired glucose tolerance.
    Kondo Y; Harada N; Sozu T; Hamasaki A; Yamane S; Muraoka A; Harada T; Shibue K; Nasteska D; Joo E; Sasaki K; Inagaki N
    Diabetes Res Clin Pract; 2013 Aug; 101(2):218-25. PubMed ID: 23806480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.